During the past decade, Optimata Ltd. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Optimata Ltd." are "Breast Cancer" (1 trials), "Colon Cancer" (1 trials), "Melanoma" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Optimata Ltd." in a lesser frequency.

Most popular intervention types in "Optimata Ltd." are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "ML-PrediCare" (1 trials) and "PrediCare" (1 trials). Other intervention names were less common.

The vast majority of trials in "Optimata Ltd." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Optimata Ltd.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Optimata Ltd., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Optimata Ltd., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".